| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 10/08/2009 | WO2009121507A2 Substituted enaminothiocarbonyl compounds |
| 10/08/2009 | WO2009121247A1 Luminescence quenchers and fluorogenic probes for detection of reactive species |
| 10/08/2009 | US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists |
| 10/08/2009 | US20090253762 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 10/08/2009 | US20090253749 Substituted enaminocarbonyl compounds |
| 10/08/2009 | US20090253736 Azaindole derivatives as cftr modulators |
| 10/08/2009 | US20090253700 N-'4-4(4-morpholinyl) phenyl!- '(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors |
| 10/08/2009 | US20090253697 Novel Indole Derivatives, Preparation Thereof as Medicinal Products and Pharmaceutical Compositions, and Especially as KDR Inhibitors |
| 10/08/2009 | US20090253694 Fused hetrocyclic compounds |
| 10/08/2009 | US20090253684 Leukotriene b4 inhibitors |
| 10/08/2009 | US20090253682 Heterocyclic derivatives for modulation of calcium channels |
| 10/08/2009 | US20090253656 Bcrp/abcg2 inhibitor |
| 10/08/2009 | US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue |
| 10/08/2009 | CA2720275A1 Indolinone compound |
| 10/08/2009 | CA2719907A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 10/08/2009 | CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof |
| 10/08/2009 | CA2718310A1 Pyridyl derivatives as cftr modulators |
| 10/08/2009 | CA2685716A1 Compounds for treating muscular dystrophy |
| 10/07/2009 | EP2107058A1 Substituted enaminothiocarbonyl compounds |
| 10/07/2009 | EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure |
| 10/07/2009 | EP2106400A2 Benzoquinazole derivatives |
| 10/07/2009 | EP2106398A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 10/07/2009 | EP1756087B1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 10/07/2009 | EP1709027B1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 10/07/2009 | EP1309566B1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 10/07/2009 | EP1308441B1 2-aminopyridine compounds and use thereof as drugs |
| 10/07/2009 | EP1248774B1 Polyhydroxystilbenes and stilbene oxides as antipsoriatic agents and protein kinase inhibitors |
| 10/07/2009 | EP0861247B1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 10/07/2009 | CN101553484A Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 10/07/2009 | CN101553468A Organic compounds |
| 10/07/2009 | CN101550132A Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 10/07/2009 | CN101550119A Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing same |
| 10/06/2009 | US7598377 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy |
| 10/06/2009 | US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 10/06/2009 | US7598285 N-[4-((1S)-1-{3-(3,5-Dichlorophenyl)-5-[6-(trifluoromethoxy)-2-naphthyl]-1H-pyrazol-1-yl}ethyl)benzoyl]- beta -alanine; type 2 diabetes, hyperglycemia, or insulin resistance |
| 10/06/2009 | US7598284 Indazole compounds as B3 adrenoceptor agonist |
| 10/06/2009 | US7598271 Crystalline paroxetine methane sulfonate |
| 10/06/2009 | US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents |
| 10/06/2009 | US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 10/06/2009 | US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents |
| 10/06/2009 | US7598250 for treating neurodegenerative disease such as Alzheimer's disease |
| 10/01/2009 | WO2009119880A1 Substituted pyrazole derivatives and use thereof |
| 10/01/2009 | WO2009119785A1 Method for purifying ethynylthymidine compound |
| 10/01/2009 | WO2009119528A1 Heterocyclic compound |
| 10/01/2009 | WO2009119167A1 Aniline derivative having anti-rna viral activity |
| 10/01/2009 | WO2009119088A1 Heterocyclic compound |
| 10/01/2009 | WO2009118765A2 Novel monoamine re-uptake inhibitor |
| 10/01/2009 | WO2009118473A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 10/01/2009 | WO2009118411A2 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 10/01/2009 | WO2009118305A1 Hydroxamate-based inhibitors of deacetylases b |
| 10/01/2009 | WO2009118254A1 Aminopiperidinyl derivatives and uses thereof |
| 10/01/2009 | WO2009074300A3 Hedgehog pathway antagonists and therapeutic applications thereof |
| 10/01/2009 | WO2009060835A8 Novel ubiquilin-binding small molecule |
| 10/01/2009 | US20090247745 adenosine A3 receptor antagonists; improved bioavailability; treatment of diseases such as asthma, COPD and ARDS, glaucoma, tumor, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases; e.g. 4-Methoxy-N-[6-(morpholin-4-yl)-4-benzylamino-3-cyanoquinolin-2-yl]-benzamide |
| 10/01/2009 | US20090247617 Process for the preparation of benzo-fused heteroaryl sulfamates |
| 10/01/2009 | US20090247587 1,3-dihydroisobenzofuran derivatives |
| 10/01/2009 | US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders |
| 10/01/2009 | US20090247503 5-demethoxyfumagillol and derivatives thereof |
| 10/01/2009 | US20090247489 Dihydroxyl compounds and compositions for cholesterol management and related uses |
| 10/01/2009 | US20090247474 3-Aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors |
| 10/01/2009 | US20090246390 Aziridine crosslinking agents having water solubilizing groups are more environmentally friendly, do not require VOCs, lower cost |
| 10/01/2009 | US20090246137 Pyridyl derivatives as cftr modulators |
| 10/01/2009 | CA2719477A1 Hydroxamate-based inhibitors of deacetylases b |
| 10/01/2009 | CA2718727A1 Heterocyclic compound |
| 10/01/2009 | CA2716961A1 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 10/01/2009 | CA2716932A1 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 10/01/2009 | CA2712468A1 Aminopiperidinyl derivatives and uses thereof |
| 09/30/2009 | EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses |
| 09/30/2009 | EP2104673A2 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 09/30/2009 | EP2104671A2 Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors |
| 09/30/2009 | EP2104670A2 Novel triazinedione derivatives as gaba-b receptor modulators |
| 09/30/2009 | EP1962849B1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 09/30/2009 | EP1711181B1 Quinoline derivatives and use thereof as mycobacterial inhibitors |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | US7595339 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics |
| 09/29/2009 | US7595329 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; gastroesophageal reflux disease, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 09/29/2009 | US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
| 09/29/2009 | CA2438891C Method for preparing optically active dihydropyrones |
| 09/29/2009 | CA2368495C Electron-deficient nitrogen heterocycle-substituted fluorescein dyes |
| 09/29/2009 | CA2348391C Chromenone and chromanone derivatives as integrin inhibitors |
| 09/29/2009 | CA2315647C Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas |
| 09/24/2009 | WO2009117269A1 Substituted 4-hydroxypyrimidine-5-carboxamides |
| 09/24/2009 | WO2009116055A1 Lamivudine : zidovudine : water 1 : 1 : 1 cocrystal |
| 09/24/2009 | WO2009115874A2 Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation |
| 09/24/2009 | WO2009115547A1 Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators |
| 09/24/2009 | WO2009087212A3 Pyridine derivatives |
| 09/24/2009 | WO2009076142A3 Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids |
| 09/24/2009 | WO2009067035A3 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition |
| 09/24/2009 | US20090239889 Spiro[2-cyclohexene-1,3'-[3H]indole]-2',4(1'H)-diones and 4-hydroxyspiro[2-cyclohexene-1,3'-[3H]indol]-2'(1'H)-ones; act as antagonists of mdm2 interactions; useful as potent and selective anticancer agents |
| 09/24/2009 | US20090239883 Treatment of Pulmonary Hypertension |
| 09/24/2009 | US20090239876 Substituted 4-Hydroxypyrimidine-5-Carboxamides |
| 09/24/2009 | US20090239866 Peptide deformylase inhibitors |
| 09/24/2009 | US20090239863 1-aryl-or 1- alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/24/2009 | US20090239860 Novel benzofuran derivative, medicinal composition containing the same, and uses of these |
| 09/24/2009 | US20090239845 Pyrazole compounds as prostaglandin receptors ligands |
| 09/24/2009 | US20090239773 Lubricant additive, lubricant composition and grease composition |
| 09/24/2009 | US20090238761 Novel Aryl Piperazine Derivatives With Medical Utility |
| 09/24/2009 | CA2718936A1 Novel heterocyclic compounds and uses therof |